Long-Term Efficacy and Safety of Eslicarbazepine Acetate (Esl) Monotherapy: Results from Bia-2093-311/Ext Study -The 2-Year Open-Label Extension of the Esl Study (Bia-2093-311)
AuthID
P-00S-KPK
P-00S-KPK